MetaCap

ARK Genomic Revolution ETF (ARKG)

BATS: ARKGARK ETF TrustHealthETFUSD

50.14-1.61 (-3.11%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

ARKG chart

Full chart

Key facts

Holdings
10
Inception
Oct 31, 2014
Issuer
ARK ETF Trust
Index tracked
—
Category
Health
52-week range
24.60 – 58.83
Volume / Avg
7.11M / 3.75M
Beta
—
Previous close
51.75

ARKG ETF today

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund from ARK ETF Trust in the Health category. It charges an expense ratio of 0.75%, or $75.00 per year on a $10,000 investment, and manages $2.22 billion in assets. Its largest holding is Twist Bioscience Corp (TWST) at 10.31% of assets, and the top 10 positions make up 62.4% of the portfolio out of 10 holdings.

ARKG is up 73.1% year to date and has gained 67.1% over the past 12 months; over five years its price has changed -33.2%. The fund's trailing dividend yield is 0.00% ($0.00 per share annually). ARKG launched on Oct 31, 2014.

Summary generated from market data by MetaCap's automated system. Methodology

ARKG top 10 holdings

ARKG holdings by weight
#HoldingWeight
1TWSTTwist Bioscience Corp10.31%
2TXG10x Genomics Inc Ordinary Shares - Class A10.02%
3TEMTempus AI Inc Class A common stock8.93%
4CRSPCRISPR Therapeutics AG5.24%
5ABSIAbsci Corp5.06%
6PSNLPersonalis Inc4.88%
7GHGuardant Health Inc4.61%
8NTRANatera Inc4.53%
9ILMNIllumina Inc4.50%
10CDNACareDx Inc4.34%

Top 10 holdings: 62.4% of assets.

ARKG performance

1 week

-7.52%

1 month

+7.02%

3 months

+19.75%

6 months

+80.29%

Year to date

+73.08%

1 year

+67.13%

3 years

+99.60%

5 years

-33.19%

ARKG price return, excluding dividends.

ETFs similar to ARKG

ARKG news

All ARKG news

ARKG ETF FAQ

What is the ARKG price today?

ARKG last traded at $50.14 as of Oct 7, 4:00 PM EDT, down 3.11% on the day.

What is ARKG's expense ratio?

ARKG has an expense ratio of 0.75%, which works out to about $75.00 per year for every $10,000 invested.

What are ARKG's top holdings?

ARKG's largest holdings are Twist Bioscience Corp (10.31%), 10x Genomics Inc Ordinary Shares - Class A (10.02%), Tempus AI Inc Class A common stock (8.93%), CRISPR Therapeutics AG (5.24%), Absci Corp (5.06%). The top 10 make up 62.4% of the fund.

How big is ARKG?

ARKG has about $2.22 billion in assets under management spread across 10 holdings.

Explore